Koelis transforms prostate cancer care with its fusion-guided platform that enables precise, image-based targeting for diagnosis and focal therapy. By combining real-time 3D mapping with multimodal imaging, Koelis helps clinicians localise lesions with accuracy while preserving as much healthy tissue as possible.​ Through Transmedic, Koelis technology is now supporting centres across Southeast Asia in advancing minimally invasive, organ-sparing approaches to prostate cancer. This partnership empowers specialists to deliver more accurate interventions, more predictable outcomes, and a better quality of life for patients.